These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18451625)

  • 1. [Current status and future progress of reproductive/developmental toxicity test].
    Akita M
    Yakugaku Zasshi; 2008 May; 128(5):765-72. PubMed ID: 18451625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():123-38. PubMed ID: 19025336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The way forward for reproductive/developmental toxicity testing.
    Balls M
    Altern Lab Anim; 2008 Dec; 36(6):713-4. PubMed ID: 19154098
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of embryonic stem cells for regulatory developmental toxicity testing in vitro--the current status of test development.
    Bremer S; Hartung T
    Curr Pharm Des; 2004; 10(22):2733-47. PubMed ID: 15320739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU research activities in alternative testing strategies: current status and future perspectives.
    Vanhaecke T; Snykers S; Rogiers V; Garthoff B; Castell JV; Hengstler JG
    Arch Toxicol; 2009 Dec; 83(12):1037-42. PubMed ID: 19908029
    [No Abstract]   [Full Text] [Related]  

  • 8. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECVAM and new technologies for toxicity testing.
    Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
    Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes.
    Bremer S; Pellizzer C; Hoffmann S; Seidle T; Hartung T
    Curr Pharm Des; 2007; 13(29):3047-58. PubMed ID: 17979746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus report on the future of animal-free systemic toxicity testing.
    Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T
    ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REACH and reproductive and developmental toxicology: still questions.
    Scialli AR; Guikema AJ
    Syst Biol Reprod Med; 2012 Feb; 58(1):63-9. PubMed ID: 22239083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to animal testing: current status and future perspectives.
    Liebsch M; Grune B; Seiler A; Butzke D; Oelgeschläger M; Pirow R; Adler S; Riebeling C; Luch A
    Arch Toxicol; 2011 Aug; 85(8):841-58. PubMed ID: 21607681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
    Trosko JE
    Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
    Seiler A; Oelgeschläger M; Liebsch M; Pirow R; Riebeling C; Tralau T; Luch A
    Arch Toxicol; 2011 Nov; 85(11):1361-72. PubMed ID: 22008952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproduction and development.
    Spielmann H
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):571-6. PubMed ID: 9599704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.
    Brown NA
    Altern Lab Anim; 2002; 30(2):177-98. PubMed ID: 11971754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.